European Archives - Page 659 of 1060 - European Medical Journal

Spanish Normative Data for TMA-93 (Binding by Images): Descriptive Analysis

TMA-93 is a French memory test that examines binding by images. Drawings of familiar objects of everyday life are displayed in semantically related pairs…

#BrainLifeGoals

#BrainLifeGoals is a social media awareness campaign from the European Federation of Neurological Associations (EFNA), which was presented at EAN this year.

EAN 2019 Interviews

Find out more about EAN from members of two of the important committees.

At Physiologically Relevant Concentrations, Valproic Acid and Lithium Carbonate Reduce Oxidative Stress in Human Astrocytoma Cells

There is growing evidence for the connection between mitochondrial alterations in psychiatric disorders and psychiatric symptoms in mitochondrial…

Benefit of Coenzyme Q10, Riboflavin, Petasites, and Relaxation in Migraine Prophylaxis: A Randomised Controlled trial

Migraine headache is one of the most common and debilitating neurological disorders. According to the European Federation of Neurological Societies (EFNS)…

A Possible Explanation For Neurodegenerative Disease

In 2015, 46.8 million individuals worldwide had a neurodegenerative disease, with 4.6 million new cases being recorded each year.1 Many of these…

Action Observation Training Increases Dynamic Functional Connectivity in Patients with Multiple Sclerosis

Motor disability has a high prevalence and dramatic effects on daily life activity of multiple sclerosis (MS) patients…

EAN 2019 Interview: The EMJ Neurology Editorial Board: A Roundtable Interview

The brain is a really fascinating organ: it is not simple at all and there are immense opportunities in trying to understand what is going on in the brain.

The Autonomic Nervous System: Delineating Historical Landmarks and Their Translation to Target Autonomic Dysfunctions in Multiple Sclerosis

Multiple sclerosis (MS) is first perceived as a disease affecting voluntary motor and sensory systems. The autonomic dysfunctions associated…

Baclofen, Naltrexone, and Sorbitol All Contribute to the Efficacy of PXT3003 in CMT1A Rats

The most common type of Charcot-Marie-Tooth disease (CMT1A) is associated with a duplication of PMP22, leading to dysmyelination, axonal loss, progressive…